Scholarlink

Background <p>Parenchymal transection represents a critical and challenging step in liver surgery. To date, there is no broadly accepted parenchymal transection technique in robotic liver surgery. This study aimed to compare the scissor hepatectomy technique to other parenchymal transection techniques.</p> Methods <p>A prospective database comprising 243 consecutive patients who underwent robotic hepatectomies at a single center was reviewed. The cohort was divided based on whether they received robotic parenchymal transection via scissor hepatectomy or alternative transection techniques. Propensity score matching and logistic regression analyses were carried out.</p> Results <p>Between 2020 and 2024, a total of 207 patients met the eligibility criteria with a median age of 64&#xa0;years (55—70). Of these, 117 (57%) patients underwent parenchymal transection by scissor hepatectomy, while alternative transection techniques (including Bipolar, SynchroSeal, VesselSealer, Hydrojet, and CUSA) were utilized in 90 (43%) patients. SH was associated with lower intraoperative blood loss in both unmatched and matched groups (71 patients in each group). Postoperative Grade III or higher morbidity was comparable between groups (13% vs. 14%, <i>p</i> &lt; 0.99). No risk factors were identified as being associated with Grade III or higher postoperative morbidity.</p> Conclusion <p>Scissor hepatectomy is demonstrated to be a safe pure robotic parenchymal transection technique. Prospective randomized trials are warranted to compare this approach to other parenchymal transection techniques.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Safety of robotic hepatic parenchymal transection using scissor hepatectomy and alternative techniques: a cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月14日

查看全文
  • Elisabeth Miller,
  • Ali Kassem,
  • Nadir Nasir,
  • Erik Rasbach,
  • Moritz Schwab,
  • Jan Heil,
  • Dorothée Sturm,
  • Marko Kornmann,
  • Nuh N. Rahbari,
  • Emrullah Birgin

摘要

Background

Parenchymal transection represents a critical and challenging step in liver surgery. To date, there is no broadly accepted parenchymal transection technique in robotic liver surgery. This study aimed to compare the scissor hepatectomy technique to other parenchymal transection techniques.

Methods

A prospective database comprising 243 consecutive patients who underwent robotic hepatectomies at a single center was reviewed. The cohort was divided based on whether they received robotic parenchymal transection via scissor hepatectomy or alternative transection techniques. Propensity score matching and logistic regression analyses were carried out.

Results

Between 2020 and 2024, a total of 207 patients met the eligibility criteria with a median age of 64 years (55—70). Of these, 117 (57%) patients underwent parenchymal transection by scissor hepatectomy, while alternative transection techniques (including Bipolar, SynchroSeal, VesselSealer, Hydrojet, and CUSA) were utilized in 90 (43%) patients. SH was associated with lower intraoperative blood loss in both unmatched and matched groups (71 patients in each group). Postoperative Grade III or higher morbidity was comparable between groups (13% vs. 14%, p < 0.99). No risk factors were identified as being associated with Grade III or higher postoperative morbidity.

Conclusion

Scissor hepatectomy is demonstrated to be a safe pure robotic parenchymal transection technique. Prospective randomized trials are warranted to compare this approach to other parenchymal transection techniques.

Graphical abstract